08:53 AM EDT, 08/05/2024 (MT Newswires) -- Health care stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) down 1.7% recently.

Actinium Pharmaceuticals ( ATNM ) shares tumbled by over 73% after the company said the Food and Drug Administration has determined that a phase 3 study of Iomab-B to treat refractory acute myeloid leukemia was not adequate to support a biologics license application.